Ignite Creation Date:
2025-12-24 @ 12:45 PM
Ignite Modification Date:
2025-12-27 @ 10:13 PM
Study NCT ID:
NCT04647461
Status:
UNKNOWN
Last Update Posted:
2020-12-01
First Post:
2020-11-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial
Sponsor:
CHA University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-01-29
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-23
First Submit QC Date:
None
Study First Post Date:
2020-12-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-23
Last Update Post Date:
2020-12-01
Last Update Post Date Type:
ACTUAL